Putting interventional radiologists in the center of their procedures
Wauwatosa, WI -- April 30, 2014 -- GE Healthcare announced today it has received Food and Drug Administration (FDA) clearance for its Discovery* IGS 740, a new rail-free mobile angiography system with a 41x41-cm detector. The Discovery IGS 740 is the first of this kind of mobile angiography system in the industry to receive FDA approval.
Philadelphia, PA, April 29, 2014 -- Data from a pooled analysis of four clinical trials, presented today at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, showed that using DaTscan™ (Ioflupane I 123 Injection) with single-photon emission computed tomography (SPECT) brain imaging was associated with a high level of diagnostic effectiveness.[i]
Advancing access to ultrasound to help boost quality of care
Wauwatosa, WISCONSIN and Ponte Vedra Beach, FL --- April 28, 2014 --- GE and the PGA TOUR have announced today the addition of a new portable ultrasound system to the Visionworks Mobile Health & Fitness Trailers on the PGA TOUR and Champions Tour. The access to GE's LOGIQ™e laptop-sized technology will potentially provide on-site medical professionals with more information at the point of care to help aid in injury diagnosis and help golfers return to play faster.
Barrington, IL -- April 15, 2014 -- GE Healthcare announced today it has completed the acquisition of CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the leading Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures.
FDA clearance arms pathologists with digital technology to help assess treatment options for breast cancer patients
PITTSBURGH -- April 14, 2014 -- GE Healthcare and UPMC today announced that the Omnyx™ Manual Read of the Digital HER2 Application has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance will allow the OmnyxTM system to be marketed in the U.S. for this intended use. Omnyx, LLC is a joint venture of UPMC and GE Healthcare.
